Acquired von Willebrand syndrome and lymphoproliferative disorders: A case report

Abstract

Abstract Acquired von Willebrand syndrome is a rare bleeding disorder often secondary to an underlying lymphoproliferative disorder. We report a case in whom response of both the acquired von Willebrand syndrome and smoldering multiple myeloma persist 14 months after daratumumab treatment discontinuation.

Keywords

• acquired von Willebrand syndrome
• bleeding
• daratumumab
• smoldering multiple myeloma